Our current and previous studies (Klink et al. 2008) demonstrated that OC cells from tumor tissues of patients with advanced ovarian cancer pre-activated autologous blood neutrophils to enhanced ROS production, in response to stimulation with PMA and fMLP. This evidence concerns the gene FPR1 and ovarian carcinoma.